Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical pharmacokinetic study of MD-352 in healthy postmenopausal female subjects
jRCT2031250069Phase 1Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of MD-352 (3 arms), sponsored by Mochida Pharmaceutical Co., Ltd. Primary endpoints: Pharmacokinetic parameters and Adverse events. Started May 2025; status: completed.
02
Drugs
MD-352
Beyond the preview
Go deeper on jRCT2031250069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250069.